Navigation Links
New Light on Jane Austen's Final Chapter
Date:12/2/2009

Novelist's symptoms point to death from TB, not Addison's, researcher says

WEDNESDAY, Dec. 2 (HealthDay News) -- The woman behind Pride and Prejudice and Emma may have died of tuberculosis rather than Addison's disease, as has long been believed, says one British scholar.

Since Jane Austen's death in 1817 at the age of 41, many historians and other experts have believed the cause was Addison's disease, which affects the adrenal glands and creates problems with blood pressure and heart function. The disease was always fatal until effective treatment became available in the 1950s.

But Katherine White, a member of the Addison's Disease Self-Help Group, analyzed Austen's letters in the two years before she died and concluded that the symptoms described by the writer suggest Addison's wasn't the culprit.

Austen said she experienced exhaustion, rheumatic pains, unusual skin discoloration and bilious attacks -- all of which could be symptoms of Addison's disease. However, she makes no mention of other symptoms -- generalized pain, weight loss, mental confusion and loss of appetite -- experienced by most people with the disease.

White noted that disseminated tuberculosis, affecting the joints and liver, "would have been more common in Jane Austen's time and would offer a simpler explanation for her symptoms."

Some medical historians have suggested that Austen could have acquired disseminated tuberculosis infection from cows or by drinking unpasteurized milk.

In 1964, physician and surgeon Zachary Cope suggested that Austen may have died from tubercular Addison's disease.

"...It is likely that Cope's hypothesis of infective tuberculosis as the source of her illness was at least partially correct, after all," White wrote.

The article was published online Nov. 30 in the journal Medical Humanities.

More information

The American Lung Association has more about tuberculosis .



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, Nov. 30, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: